Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division Sort ascending
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Sort ascending Business Functional Area Erscheinungsdatum
Senior Principal Clinical Data Standards Specialist Mumbai (Office) Indien Development Innovative Medicines Research & Development Okt 18, 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spanien Development Innovative Medicines Research & Development Okt 18, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Irland Development Innovative Medicines Research & Development Okt 18, 2024
RA Specialist Croatia Kroatien Development Innovative Medicines Research & Development Okt 18, 2024
Senior Patient Safety Specialist Seoul Südkorea Development Innovative Medicines Research & Development Okt 20, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Feasibility Manager INSURGENTES Mexiko Development Innovative Medicines Research & Development Okt 16, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Head, Clinical Development Business Solutions Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 10, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Irland Development Innovative Medicines Research & Development Okt 14, 2024
Associate Director, Clinical Processes & Solutions Dublin (Novartis Corporate Center (NOCC)) Irland Development Innovative Medicines Research & Development Okt 14, 2024
Head Clinical Development Business Solutions East Hanover USA Development Innovative Medicines Research & Development Okt 18, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) Frankreich Development Innovative Medicines Research & Development Sep 04, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentinien Development Innovative Medicines Research & Development Aug 15, 2024
RA Manager INSURGENTES Mexiko Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Research Medical Advisor Barcelona Gran Vía Spanien Development Innovative Medicines Research & Development Sep 06, 2024
Senior Clinical Research Associate (Remote) Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Okt 17, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Analytical Expert (Associate Director, Science & Technology) Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 10, 2024
Medical Safety Lead Hyderabad (Office) Indien Development Innovative Medicines Research & Development Okt 10, 2024
Technology Product Manager Hyderabad (Office) Indien Development Innovative Medicines Research & Development Okt 11, 2024
Associate Director, Business Transformation & Engagement Barcelona Gran Vía Spanien Development Innovative Medicines Communications & Public Affairs Okt 23, 2024
Senior Global Program Regulatory Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 24, 2024
Senior Global Program Regulatory Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 24, 2024
Global Program Regulatory Manager - Life Cycle Management London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 24, 2024
Global Program Regulatory Director London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 24, 2024
Global Program Regulatory Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 24, 2024
Associate Director AI & Automation Lead London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Data and Digital Okt 24, 2024
Associate Director, Data Engineering Lead London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Data and Digital Okt 24, 2024
Technician, Science & Technology - Analytical Development East Hanover USA Development Innovative Medicines Research & Development Okt 24, 2024
Senior Global Labelling Coordinator London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 25, 2024
Global Labelling Manager Dublin (Novartis Corporate Center (NOCC)) Irland Development Innovative Medicines Research & Development Okt 25, 2024
RA Head India Mumbai (Head Office) Indien Development Sandoz Research & Development Okt 25, 2024
Analytical Expert – Trace Level Analytics (m/f/d) Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 25, 2024
Expert Science & Technology – Trace level analytics (e.g. nitrosamines, genotoxic impurities) Basel (City) Schweiz Development Innovative Medicines Research & Development Okt 25, 2024
Director, Statistical Programming East Hanover (New Jersey) USA Development Innovative Medicines Research & Development Okt 25, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 07, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 16, 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 16, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 16, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 18, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 21, 2024
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 23, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.